{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:38:46Z","timestamp":1795081126870,"version":"4.10.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81672518"],"award-info":[{"award-number":["81672518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the 3-year Public Health Program of the Shanghai Health Commission","award":["GWV-10.1-XK17"],"award-info":[{"award-number":["GWV-10.1-XK17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15160-2","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:21:16Z","timestamp":1762874476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rapidly increasing kidney cancer burden among young adults: insights from the 1990\u20132021 Global Burden of Disease Study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ming","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaifen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"3","key":"15160_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"15160_CR2","first-page":"2022\u2013vol3","volume":"39","author":"S Bahadoram","year":"2022","unstructured":"Bahadoram S, Davoodi M, Hassanzadeh S, et al. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):2022-vol3 PMID: 35819037.","journal-title":"G Ital Nefrol."},{"key":"15160_CR3","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975\u20132018. National Cancer Institute; 2020. https:\/\/seer.cancer.gov\/archive\/csr\/1975_2018. Accessed 10 June 2024."},{"key":"15160_CR4","unstructured":"Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2024. https:\/\/gco.iarc.fr\/today. Accessed 10 June 2024."},{"issue":"5","key":"15160_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82(5):529\u201342. https:\/\/doi.org\/10.1016\/j.eururo.2022.08.019.","journal-title":"Eur Urol"},{"issue":"1","key":"15160_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00308-8","volume":"7","author":"F Spreafico","year":"2021","unstructured":"Spreafico F, Fernandez CV, Brok J, et al. Wilms tumour. Nat Rev Dis Primers. 2021;7(1):75. https:\/\/doi.org\/10.1038\/s41572-021-00308-8.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"15160_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor A, Lortet-Tieulent J, Laversanne M, et al. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519\u201330. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.002.","journal-title":"Eur Urol"},{"issue":"3","key":"15160_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/wjon1279","volume":"11","author":"SA Padala","year":"2020","unstructured":"Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79\u201387. https:\/\/doi.org\/10.14740\/wjon1279.","journal-title":"World J Oncol"},{"issue":"9","key":"15160_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41581-024-00863-9","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye NC, Ortiz A, Zoccali C, Stel VS, Jager KJ. The impact of population ageing on the burden of chronic kidney disease. Nat Rev Nephrol. 2024;20(9):569\u201385. https:\/\/doi.org\/10.1038\/s41581-024-00863-9.","journal-title":"Nat Rev Nephrol"},{"key":"15160_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101762","volume":"67","author":"C Palumbo","year":"2020","unstructured":"Palumbo C, Pecoraro A, Rosiello G, et al. Renal cell carcinoma incidence rates and trends in young adults aged 20\u201339 years. Cancer Epidemiol. 2020;67:101762. https:\/\/doi.org\/10.1016\/j.canep.2020.101762.","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"15160_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s11912-013-0327-3","volume":"15","author":"I Magrath","year":"2013","unstructured":"Magrath I, Epelman S. Cancer in adolescents and young adults in countries with limited resources. Curr Oncol Rep. 2013;15(4):332\u201346. https:\/\/doi.org\/10.1007\/s11912-013-0327-3.","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"15160_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21637","volume":"70","author":"KD Miller","year":"2020","unstructured":"Miller KD, Fidler-Benaoudia M, Keegan TH, et al. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70(6):443\u201359. https:\/\/doi.org\/10.3322\/caac.21637.","journal-title":"CA Cancer J Clin"},{"key":"15160_CR13","unstructured":"United Nations Development Programme (UNDP). Human Development Report 2021\u201322. 2023. https:\/\/hdr.undp.org\/content\/human-development-report-2023-24. Accessed 10 June 2024."},{"key":"#cr-split#-15160_CR14.1","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Socio-Demographic Index (SDI) 1950-2021. Institute for Health Metrics and Evaluation (IHME)"},{"key":"#cr-split#-15160_CR14.2","unstructured":"2024. https:\/\/ghdx.healthdata.org\/record\/global-burden-disease-study-2021-gbd-2021-socio-demographic-index-sdi-1950-2021. Accessed 10 June 2024."},{"key":"15160_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00757-8","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet"},{"issue":"10062","key":"15160_CR16","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, GATHER Working Group, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388(10062):e19\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(16)30388-9.","journal-title":"Lancet"},{"key":"#cr-split#-15160_CR17.1","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Demographics 1950-2021. Institute for Health Metrics and Evaluation (IHME)"},{"key":"#cr-split#-15160_CR17.2","unstructured":"2024. https:\/\/ghdx.healthdata.org\/record\/ihme-data\/global-burden-disease-study-2021-gbd-2021-demographics-1950-2021. Accessed 10 June 2024."},{"issue":"3","key":"15160_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420\u201344. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987.","journal-title":"JAMA Oncol"},{"issue":"10440","key":"15160_CR19","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4.","journal-title":"Lancet"},{"issue":"10064","key":"15160_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(16)31919-5.","journal-title":"Lancet"},{"issue":"10","key":"15160_CR21","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1016\/S2352-3018(21)00152-1","volume":"8","author":"GBD 2019 HIV Collaborators","year":"2021","unstructured":"GBD 2019 HIV Collaborators. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990\u20132019, for 204 countries and territories: the Global Burden of Diseases Study 2019. Lancet HIV. 2021;8(10):e633\u201351. https:\/\/doi.org\/10.1016\/S2352-3018(21)00152-1.","journal-title":"Lancet HIV."},{"key":"15160_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lungcan.2020.12.007","volume":"152","author":"X Yang","year":"2021","unstructured":"Yang X, Man J, Chen H, et al. Temporal trends of the lung cancer mortality attributable to smoking from 1990 to 2017: a global, regional and national analysis. Lung Cancer. 2021;152:49\u201357. https:\/\/doi.org\/10.1016\/j.lungcan.2020.12.007.","journal-title":"Lung Cancer"},{"issue":"3","key":"15160_CR23","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","volume":"4","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4(3):e137\u201347. https:\/\/doi.org\/10.1016\/S2468-2667(18)30267-6.","journal-title":"Lancet Public Health"},{"issue":"5","key":"15160_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3322\/caac.21858","volume":"74","author":"F Islami","year":"2024","unstructured":"Islami F, Marlow EC, Thomson B, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA Cancer J Clin. 2024;74(5):405\u201332. https:\/\/doi.org\/10.3322\/caac.21858.","journal-title":"CA Cancer J Clin"},{"issue":"10481","key":"15160_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"GBD 2021 Adult BMI Collaborators","year":"2025","unstructured":"GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405(10481):813\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(25)00355-1.","journal-title":"Lancet."},{"issue":"12","key":"15160_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamapediatrics.2019.3310","volume":"173","author":"P Song","year":"2019","unstructured":"Song P, Zhang Y, Yu J, et al. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(12):1154\u201363. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.3310.","journal-title":"JAMA Pediatr"},{"issue":"10","key":"15160_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.19022","volume":"3","author":"JL Barrington-Trimis","year":"2020","unstructured":"Barrington-Trimis JL, Braymiller JL, Unger JB, et al. Trends in the age of cigarette smoking initiation among young adults in the US from 2002 to 2018. JAMA Netw Open. 2020;3(10):e2019022. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19022.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"15160_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10654-020-00650-3","volume":"35","author":"MCS Wong","year":"2020","unstructured":"Wong MCS, Huang J, Wang J, et al. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur J Epidemiol. 2020;35(7):673\u201383. https:\/\/doi.org\/10.1007\/s10654-020-00650-3.","journal-title":"Eur J Epidemiol"},{"issue":"10082","key":"15160_CR29","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","volume":"389","author":"GBD 2015 Tobacco Collaborators","year":"2017","unstructured":"GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990\u20132015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885\u2013906. https:\/\/doi.org\/10.1016\/S0140-6736(17)30819-X.","journal-title":"Lancet."},{"issue":"5","key":"15160_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/MOU.0000000000000656","volume":"29","author":"KM Craig","year":"2019","unstructured":"Craig KM, Poppas DP, Akhavan A. Pediatric renal cell carcinoma. Curr Opin Urol. 2019;29(5):500\u20134. https:\/\/doi.org\/10.1097\/MOU.0000000000000656.","journal-title":"Curr Opin Urol"},{"issue":"2","key":"15160_CR31","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1016\/j.clgc.2019.09.012","volume":"18","author":"PS Sierra","year":"2020","unstructured":"Sierra PS, Cordeiro MD, Albuquerque EV, et al. Oncologic outcomes in young adults with kidney cancer treated during the targeted therapy era. Clin Genitourin Cancer. 2020;18(2):e134\u201344. https:\/\/doi.org\/10.1016\/j.clgc.2019.09.012.","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"15160_CR32","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/1055-9965.EPI-21-0913","volume":"31","author":"JK Sheth Bhutada","year":"2022","unstructured":"Sheth Bhutada JK, Hwang AE, Liu L, et al. Survival of adolescents and young adults with prevalent poor-prognosis metastatic cancers: a population-based study of contemporary patterns and their implications. Cancer Epidemiol Biomarkers Prev. 2022;31(4):900\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-0913.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"15160_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","volume":"20","author":"RJ Motzer","year":"2022","unstructured":"Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(1):71\u201390. https:\/\/doi.org\/10.6004\/jnccn.2022.0001.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"15160_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/bjs.10523","volume":"104","author":"SH Rossi","year":"2017","unstructured":"Rossi SH, Hsu R, Blick C, et al. Meta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography. Br J Surg. 2017;104(6):648\u201359. https:\/\/doi.org\/10.1002\/bjs.10523.","journal-title":"Br J Surg"},{"issue":"14","key":"15160_CR35","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMoa2035716","volume":"384","author":"R Motzer","year":"2021","unstructured":"Motzer R, Alekseev B, Rha SY, CLEAR Trial Investigators, et al. Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma. N Engl J Med. 2021;384(14):1289\u2013300. https:\/\/doi.org\/10.1056\/NEJMoa2035716.","journal-title":"N Engl J Med"},{"issue":"1","key":"15160_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1470-2045(19)30735-1","volume":"21","author":"BI Rini","year":"2020","unstructured":"Rini BI, Pal SK, Escudier BJ, et al. Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study. Lancet Oncol. 2020;21(1):95\u2013104. https:\/\/doi.org\/10.1016\/S1470-2045(19)30735-1.","journal-title":"Lancet Oncol"},{"issue":"10","key":"15160_CR37","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41431-019-0455-9","volume":"27","author":"RS Laskar","year":"2019","unstructured":"Laskar RS, Muller DC, Li P, et al. Sex specific associations in genome wide association analysis of renal cell carcinoma. Eur J Hum Genet. 2019;27(10):1589\u201398. https:\/\/doi.org\/10.1038\/s41431-019-0455-9.","journal-title":"Eur J Hum Genet"},{"issue":"17","key":"15160_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176089","volume":"21","author":"KH Lee","year":"2020","unstructured":"Lee KH, Kim BC, Jeong SH, et al. Histone demethylase LSD1 regulates kidney cancer progression by modulating androgen receptor activity. Int J Mol Sci. 2020;21(17):6089. https:\/\/doi.org\/10.3390\/ijms21176089.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"15160_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrurol.2014.159","volume":"11","author":"L Stone","year":"2014","unstructured":"Stone L. Kidney cancer: androgen receptor\u2013a new target in renal cell carcinoma? Nat Rev Urol. 2014;11(8):425. https:\/\/doi.org\/10.1038\/nrurol.2014.159.","journal-title":"Nat Rev Urol"},{"key":"15160_CR40","unstructured":"World Health Organization. WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000\u20132025. 4th ed. World Health Organization; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240039322. Accessed 10 June 2024."},{"issue":"8","key":"15160_CR41","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamapediatrics.2024.1576","volume":"178","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liu J, Ni Y, et al. Global prevalence of overweight and obesity in children and adolescents: a systematic review and meta-analysis. JAMA Pediatr. 2024;178(8):800\u201313. https:\/\/doi.org\/10.1001\/jamapediatrics.2024.1576.","journal-title":"JAMA Pediatr"},{"issue":"10292","key":"15160_CR42","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/S0140-6736(21)01169-7","volume":"397","author":"GBD 2019 Tobacco Collaborators","year":"2021","unstructured":"GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990\u20132019: a systematic analysis from the global burden of disease study 2019. Lancet. 2021;397(10292):2337\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(21)01169-7.","journal-title":"Lancet"},{"issue":"11","key":"15160_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41585-023-00781-8","volume":"20","author":"R Campi","year":"2023","unstructured":"Campi R, Rebez G, Klatte T, et al. Effect of smoking, hypertension and lifestyle factors on kidney cancer - perspectives for prevention and screening programmes. Nat Rev Urol. 2023;20(11):669\u201381. https:\/\/doi.org\/10.1038\/s41585-023-00781-8.","journal-title":"Nat Rev Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15160-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15160-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15160-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:21:23Z","timestamp":1762874483000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15160-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15160"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15160-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). All procedures have been approved by the Institutional Review Board of Second Military Medical University (Approval No. GWV-10.1-XK17). Patient consent is not applicable because this study only uses public information freely available and does not contain any personal or medical information about identifiable living individuals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1748"}}